Inventor · disambiguated record
Marc Derive
Also filed as: DERIVE MARC
5 granted patents·4 pending applications·11 citations·filing 2011–2024
73Inventor score
Top patents by PatentIndex Score
9 records- 0177US9255136B2Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereofGIBOT SEBASTIEN·Filed 2011·Granted Feb 9, 2016·3 cites·12 claims
- 0276US9815883B2Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereofGIBOT SEBASTIEN·Filed 2015·Granted Nov 14, 2017·3 cites·4 claims
- 0375US9657081B2Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseasesINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2013·Granted May 23, 2017·4 cites·6 claims
- 0463US12364733B1Method for treating septic shockINOTREM·Filed 2024·Granted Jul 22, 2025·0 cites·16 claims
- 0557US10948498B2Methods and kits for predicting the risk of having a cardiovascular disease or eventINOTREM·Filed 2014·Granted Mar 16, 2021·1 cites·9 claims
- 0645US2024254225A1Anti-trem-1 antibodiesINOTREM·Filed 2022·Application pending·0 cites
- 0740US2023273208A1Soluble trem-1 as a marker of severity or complications for a subject suffering from a coronavirus infectionINOTREM·Filed 2021·Application pending·0 cites
- 0837US2021364532A1Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapyINOTREM·Filed 2019·Application pending·0 cites
- 0936US2023201301A1Trem-1 inhibitor for use in the treatment of a subject suffering from a coronavirus infectionINOTREM·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Derive files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →